[go: up one dir, main page]

WO2002048146A3 - Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel - Google Patents

Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel Download PDF

Info

Publication number
WO2002048146A3
WO2002048146A3 PCT/EP2001/014577 EP0114577W WO0248146A3 WO 2002048146 A3 WO2002048146 A3 WO 2002048146A3 EP 0114577 W EP0114577 W EP 0114577W WO 0248146 A3 WO0248146 A3 WO 0248146A3
Authority
WO
WIPO (PCT)
Prior art keywords
atoms
membered
atom
imidazoazines
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/014577
Other languages
English (en)
French (fr)
Other versions
WO2002048146A2 (de
Inventor
Oliver Cullmann
Markus Gewehr
Wassilios Grammenos
I Blasco Jordi Tormo
Bernd Mueller
Hubert Sauter
Andreas Gypser
Thomas Grote
Joachim Rheinheimer
Ingo Rose
Frank Schieweck
Eberhard Ammermann
Siegfried Strathmann
Gisela Lorenz
Reinhard Stierl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to AU2002224927A priority Critical patent/AU2002224927A1/en
Priority to US10/433,440 priority patent/US20040058938A1/en
Priority to EP01994779A priority patent/EP1343785A2/de
Publication of WO2002048146A2 publication Critical patent/WO2002048146A2/de
Publication of WO2002048146A3 publication Critical patent/WO2002048146A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Die Verwendung von substituierten Imidazoazinen der Formel (I), in der die Variablen folgende Bedeutung haben: R1 Alkyl, Phenyl, Phenylalkyl, Naphthyl, Anthracenyl, Cycloalkyl, 5- oder 6-gliedriges Hetaryl oder 5- oder 6-gliedriges Heterocyclyl, enthaltend ein bis drei N-Atome und/oder ein O- oder S-Atom oder ein oder zwei O- und/oder S-Atome, oder kondensiertes 8- bis 12-gliederiges Hetaryl oder kondensiertes 8- bis 12-gliederiges Heterocyclyl, enthaltend ein bis vier N-Atome und/oder ein O- oder S-Atom oder ein oder zwei O- und/oder A-Atome, wobei R1 unsubstituiert oder wie in der Beschreibung substituiert sein kann; R2, R3 Wasserstoff, Alkyl, Alkenyl, Alkinyl, Halogenalkyl, Halogenalkenyl, Halogenalkinyl, Trialkylsilylalkyl, Phenyl, Phenylalkyl oder R2, R3 gemeinsam mit dem überbrückenden N-Atom einen 5- oder 6-gliedrigen heterocyclischen oder heteroaromatischen Ring bilden, der durch ein bis drei N-Atome und/oder ein O- oder S-Atom oder ein oder zwei O- und/oder S-Atome unterbrochen sein kann; A, B, N oder CR?4; R4, R5, R6¿ Wasserstoff, Halogen, Cyano, Nitro, Hydroxy, Alkyl, Halogenalkyl, Cycloalkyl, Alkoxy, Halogenalkoxy, Alkylthio, Amino, Alkylamino, Dialkylamino, Alkenyl, Alkenyloxy, Alkinyl oder Alkinyloxy; zur Bekämpfung von phytopathogenen Schadpilzen, sie enthaltende Mittel, neue Imidazoazine und Verfahren zu deren Herstellung.
PCT/EP2001/014577 2000-12-13 2001-12-12 Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel Ceased WO2002048146A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002224927A AU2002224927A1 (en) 2000-12-13 2001-12-12 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
US10/433,440 US20040058938A1 (en) 2000-12-13 2001-12-12 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
EP01994779A EP1343785A2 (de) 2000-12-13 2001-12-12 Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10061983 2000-12-13
DE10061983.5 2000-12-13

Publications (2)

Publication Number Publication Date
WO2002048146A2 WO2002048146A2 (de) 2002-06-20
WO2002048146A3 true WO2002048146A3 (de) 2002-11-14

Family

ID=7666908

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/014577 Ceased WO2002048146A2 (de) 2000-12-13 2001-12-12 Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel

Country Status (4)

Country Link
US (1) US20040058938A1 (de)
EP (1) EP1343785A2 (de)
AU (1) AU2002224927A1 (de)
WO (1) WO2002048146A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007014510A (es) * 2005-05-20 2008-02-05 Array Biopharma Inc Compuestos inhibidores de raf y metodos de uso de los mismos.
CA2730280A1 (en) * 2008-07-10 2010-01-14 Southern Research Institute 5-quinolinone and imidazopyridine compounds and use thereof
CN102216298B (zh) * 2008-09-16 2014-04-16 Csir公司 作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶
US20120220581A1 (en) 2009-10-30 2012-08-30 Janssen-Cilag, S.A. IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
EP2723744B1 (de) 2011-06-27 2016-03-23 Janssen Pharmaceutica, N.V. 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]-chinoxalin-derivate
RU2657540C2 (ru) 2012-06-26 2018-06-14 Янссен Фармацевтика Нв Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств
ES2607184T3 (es) 2012-07-09 2017-03-29 Janssen Pharmaceutica, N.V. Inhibidores de la enzima fosfodiesterasa 10
RU2015118985A (ru) * 2012-11-14 2017-01-10 Ф. Хоффманн-Ля Рош Аг Производные имидазопиридина
PH12020552066A1 (en) 2014-02-13 2022-05-11 Incyte Corp Cyclopropylamines as lsd1 inhibitors
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
RS59534B1 (sr) 2014-02-13 2019-12-31 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
ES2672797T3 (es) 2014-02-13 2018-06-18 Incyte Corporation Ciclopropilaminas como inhibidores de LSD1
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
TWI687419B (zh) 2014-07-10 2020-03-11 美商英塞特公司 作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
WO2016007736A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EP3626720A1 (de) 2015-04-03 2020-03-25 Incyte Corporation Heterocyclische verbindungen als lsd1-hemmer
MX389824B (es) 2015-08-12 2025-03-20 Incyte Holdings Corp Sales de un inhibidor de dimetilasa 1 especifica para lisina (lsd1).
TW201718581A (zh) 2015-10-19 2017-06-01 英塞特公司 作為免疫調節劑之雜環化合物
LT3377488T (lt) 2015-11-19 2023-01-10 Incyte Corporation Heterocikliniai junginiai, kaip imunomoduliatoriai
US20170174679A1 (en) 2015-12-22 2017-06-22 Incyte Corporation Heterocyclic compounds as immunomodulators
IL262488B (en) 2016-04-22 2022-08-01 Incyte Corp lsdi inhibitor formulations
MA44860A (fr) 2016-05-06 2019-03-13 Incyte Holdings Corp Composés hétérocycliques utilisés comme immunomodulateurs
WO2017205464A1 (en) 2016-05-26 2017-11-30 Incyte Corporation Heterocyclic compounds as immunomodulators
HUE060256T2 (hu) 2016-06-20 2023-02-28 Incyte Corp Heterociklusos vegyületek mint immunmodulátorok
US20180016260A1 (en) 2016-07-14 2018-01-18 Incyte Corporation Heterocyclic compounds as immunomodulators
ES2941716T3 (es) 2016-08-29 2023-05-25 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
JP7303108B2 (ja) 2016-12-22 2023-07-04 インサイト・コーポレイション 免疫調節剤としての二環式複素芳香環化合物
CN116115764A (zh) 2016-12-22 2023-05-16 因赛特公司 四氢咪唑并[4,5-c]吡啶衍生物作为pd-l1内在化诱导剂
EP3558989B1 (de) 2016-12-22 2021-04-14 Incyte Corporation Triazolo[1,5-a]pyridin-derivate als immunmodulatoren
WO2018119266A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Benzooxazole derivatives as immunomodulators
WO2018119221A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Pyridine derivatives as immunomodulators
AU2018346331B2 (en) * 2017-10-04 2023-08-24 Dana-Farber Cancer Institute, Inc. Small molecule inhibition of transcription factor SALL4 and uses thereof
ES3030010T3 (en) 2018-03-30 2025-06-26 Incyte Corp Heterocyclic compounds as immunomodulators
BR112020022936A2 (pt) 2018-05-11 2021-02-02 Incyte Corporation derivados de tetra-hidro-imidazo[4,5-c]piridina como imunomoduladores de pd-l1
CN108794471B (zh) * 2018-08-27 2020-04-28 青岛农业大学 苯并咪唑类化合物的合成方法及其农用生物活性
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
CA3150434A1 (en) 2019-08-09 2021-02-18 Incyte Corporation Salts of a pd-1/pd-l1 inhibitor
IL291471B2 (en) 2019-09-30 2025-04-01 Incyte Corp Pyrimido[3,2–D]pyrimidine compounds as immunomodulators
JP2023500395A (ja) 2019-11-11 2023-01-05 インサイト・コーポレイション Ｐｄ－１／ｐｄ－ｌ１阻害剤の塩及び結晶形態
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
TW202233616A (zh) 2020-11-06 2022-09-01 美商英塞特公司 用於製備ｐｄ－１／ｐｄ－ｌ１抑制劑以及其鹽及結晶形式之方法
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina
AR132351A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215382A1 (de) * 1985-09-17 1987-03-25 BASF Aktiengesellschaft 7-Amino-azolo[1,5-a]pyrimidine und diese enthaltende Fungizide
WO2001027109A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridin-3-yl)-amin-derivate
WO2001027111A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Bicyclische imidazo-3-yl-aminderivate
WO2001027110A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate
WO2002006286A2 (en) * 2000-07-14 2002-01-24 Bristol-Myers Squibb Pharma Company IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215382A1 (de) * 1985-09-17 1987-03-25 BASF Aktiengesellschaft 7-Amino-azolo[1,5-a]pyrimidine und diese enthaltende Fungizide
WO2001027109A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridin-3-yl)-amin-derivate
WO2001027119A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Substanzbibliothek enthaltend bicyclische imidazo-5-yl-amine und/oder bicyclische imidazo-3-yl-amine
WO2001027111A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Bicyclische imidazo-3-yl-aminderivate
WO2001027110A2 (de) * 1999-10-08 2001-04-19 Grünenthal GmbH Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate
WO2002006286A2 (en) * 2000-07-14 2002-01-24 Bristol-Myers Squibb Pharma Company IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BIENAYME, HUGUES ET AL: "A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles", ANGEWANDTE CHEMIE, INTERNATIONAL EDITION (1998), 37(16), 2234-2237, XP000978871 *
BLACKBURN, CHRISTOPHER ET AL: "A novel dealkylation affording 3-aminoimidazo[1,2-a]pyridines: access to new substitution patterns by solid-phase synthesis", TETRAHEDRON LETTERS (2000), 41(10), 1495-1500, XP004189781 *
BLACKBURN, CHRISTOPHER ET AL: "Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation", TETRAHEDRON LETTERS (1998), 39(22), 3635-3638, XP004118699 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SUGIURA, SUMI ET AL: "Synthesis of Cypridina luciferin and related compounds. 5. Structure of imidazo[1,2-.alpha.]pyrazine derivatives", XP002201717, retrieved from STN Database accession no. 73:45460 *
GROEBKE, KATRIN ET AL: "Synthesis of imidazo[1,2-a]-annulated pyridines, pyrazines, and pyrimidines by a novel three-component condensation", SYNLETT (1998), (6), 661-663, XP001073924 *
VARMA, RAJENDER S. ET AL: "Microwave-accelerated three-component condensation reaction on clay: solvent-free synthesis of imidazo[1,2-a] annulated pyridines, pyrazines, and pyrimidines", TETRAHEDRON LETTERS (1999), 40(43), 7665-7669, XP004179890 *
YAKUGAKU ZASSHI (1970), 90(4), 431-5 *

Also Published As

Publication number Publication date
EP1343785A2 (de) 2003-09-17
US20040058938A1 (en) 2004-03-25
AU2002224927A1 (en) 2002-06-24
WO2002048146A2 (de) 2002-06-20

Similar Documents

Publication Publication Date Title
WO2002048146A3 (de) Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
IL159607A0 (en) 7-amino triazolopyrimidines for controlling harmful fungi
YU65902A (sh) Farmaceutske smeše koje sadrže derivate 3-aminoazetidina, novi derivati i njihovo spravljanje
HUP0301534A2 (hu) Kinolonszármazék antidótumot tartalmazó herbicid készítmények és alkalmazásuk
AU4742293A (en) Carboxanilides, their preparation and compositions containing them for controlling harmful fungi
WO2003039451A3 (en) Thiazole pyridazinones as adenosine antagonists
MY131288A (en) Pyrazole carboxanilide fungicides
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ES8406447A1 (es) Un procedimiento de preparacion de un derivado de ciano-2-benzimidazol.
ES537182A0 (es) Procedimiento de obtencion de compuestos de 1-aril-2-(3-(4-trifluormetilestiril)-1,2,4-triazol-1-il)-1-c 1,2,4,-triazol-1-il-metil) etanol de efecto antifugal.
WO2003029243A3 (de) 2-aryloxy-6-pyrazolyl-pyridine
ATE85498T1 (de) Biozide zusammensetzung.
ATE550332T1 (de) 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
WO2004041824A3 (en) 6-(2-halogenphenyl)-triazolopyrimidines derivatives and their use as fungicide
EP0791572A4 (de) Substituierte bicycloheptandione und herbizide
AU2001223629A1 (en) Fungicidal 6-(trifluoromethyl-phenyl)-triazolopyrimidines
MX2022002898A (es) Compuesto de 7-oxa-3,4-diazabiciclo-[4.1.0]-4-hepten-2-ona y herbicida.
MXPA04000371A (es) 6- (2-tolil) - triazolopirimidinas substituidas.
WO2000020399A3 (de) Verwendung von substituierten 5-hydroxypyrazolen, neue 5-hydroxypyrazole, verfahren zu deren herstellung, sowie sie enthaltende mittel
DE60116092D1 (de) Fungicide triazolopyrimid-7-ylidenamine
JPS55167206A (en) Industrial bactericidal and fungicidal agent
WO2002049438A3 (de) Fungizide mischungen auf der basis von carbamaten

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001994779

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10433440

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001994779

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001994779

Country of ref document: EP